Determination of iron(II) and iron(III) via static quenching of the fluorescence of tryptophan-protected copper nanoclusters.

"Tryptophan-coated blue fluorescent copper nanocluster (CuNC@Trp) was prepared by a strategy where Trp acts as both the reducing and capping agent. The fluorescence of the CuNC, with excitation/emission peaks at 340/405 nm, is selectively quenched by iron(II) and iron(III) ions. Studying the mechanism of this interaction revealed that Fe2+ and Fe3+ ions can make a ground state complex with the protecting ligand which can result in quenching of the cluster emission. Structural and optical properties of the modified CuNC were investigated by ESI-MS, DLS, TEM, UV-vis and photoluminescence. The effects of pH value and temperature, time of interaction, and cluster volume were optimized. Under optimized conditions, the probe response is linear in concentration range of 10-1000 µM for Fe(II) and Fe(III) with the relative standard deviations of 0.13 and 0.14% (n = 5) respectively. The respective limits of detection are 3.0 and 2.2 µM. The method was successfully used for determination of trace amount of both ions in spiked water, blood and iron supplement tablets. The results were in good agreement with those obtained by the ICP-AES method." Graphical abstractThe scheme represents the synthesis of CuNC@Trp at basic conditions and at elevated temperature. The emission of the cluster decreases due to static quenching of fluorescence by iron ions.

Fluorometric determination of lead(II) by using aptamer-functionalized upconversion nanoparticles and magnetite-modified gold nanoparticles.

A fluorescent nanoprobe for Pb(II) has been developed by employing aptamer-functionalized upconversion nanoparticles (UCNPs) and magnetic Fe3O4-modified (MNPs) gold nanoparticles (GNPs). First, aptamer-functionalized UCNPs and aptamer-functionalized magnetic GNPs were synthesized to obtained the fluorescent nanoprobe. The particles were combined by adding a complementary ssDNA. In the absence of Pb(II), the UCNPs, MNPs and GNPs are linked via complementary base pairing. This led to a decrease in the green upconversion fluorescence peaking at 547 nm (under 980 nm excitation). In the presence of Pb(II), the dsDNA between UCNPs and MNPs-GNPs is cleaved, and fluorescence recovers. This effect allows Pb(II) to be quantified, with a wide working range of 25-1400 nM and a lower detection limit of 5.7 nM. The nanoprobe gave satisfactory results when analyzing Pb(II) in tea and waste water. Graphical abstractSchematic representation of fluorescent nanoprobe based on fluorescence resonance energy transfer (FRET) between upconversion nanoparticles (UCNPs) and gold nanoparticles (GNPs)-Fe3O4 magnetic nanoparticles (MNPs) for detection of Pb2+.

High throughput screening assay of alpha(1G) T-type Ca2+ channels and comparison with patch-clamp studies.

Whole-cell patch-clamp-based electrophysiological techniques are powerful tools for examining the biophysical and pharmacological properties of ion channels. However, the recent validation of ion channels as novel drug targets necessitates the development of a faster screening method for ion channels. Therefore, we have developed a rapid, reliable, and sensitive cell-based high throughput screening (HTS) assay for T-type Ca2+ channels. We had previously constructed HEK293/alpha(1G)/Kir2.1 cell lines that stably expressed alpha(1G) and Kir2.1 subunits [1] and found that alpha(1G) T-type channel-sensitive Ca2+ signals were detected by the application of high concentrations of KCl under fura-2-based single cell measurements of intracellular Ca2+ concentration ([Ca2+](i)). In the present study, we applied HEK293/alpha (1G)/Kir2.1 cells to the FDSS6000 (Functional Drug Screening System) to develop a fast and reliable cell-based HTS method for alpha(1G) T-type Ca2+ channels. After detecting 70 mM KCl-induced [Ca2+](i) increases using the FDSS6000 system, we verified this new alpha(1G) channel HTS system by examining two T-type Ca2+ channel blockers, Ni2+ and mibefradil, and measuring the Z'-factor (Z' factor = 0.66) in 96-well plates. Furthermore, we assayed selected 3,4-dihydroquinazolin derivatives using this FDSS6000-based alpha(1G) channel HTS system at the level of IC(50) values and compared the results with those obtained from whole-cell patch-clamp recordings. Taken together, our results suggest that the FDSS6000-based alpha(1G) channel HTS system is a fast and feasible assay for alpha(1G) T-type Ca2+ channels. This assay can be utilized as a primary screening method for T-type Ca2+ channel-targeted chemicals and for the development of HTS systems for other types of ion channels.

Determination of residual oil in diesel oil by spectrofluorimetric and chemometric analysis.

Multivariate calibration (PLS), principal components analysis (PCA) and linear discriminant analysis (LDA), associated to synchronous spectrofluorimetry, were used to identify and quantify non-transesterified residual vegetable oil in diesel oil with the addition of 2% of biodiesel (B2). The addition of residual oil, one of the easiest ways of adultering fuel, damages engines and leads to tax evasion. Using this method, the samples of diesel oil, B2, and B2 contaminated with residual oil were classified correctly and separated into three well-defined groups. The quantification of residual oil in B2 was carried out in the 0-25% (w/w) band, RMSEC and RMSEP values ranging from 0.26 to 0.48% (w/w) and 1.6-2.6% (w/w), respectively. The method is highly sensitive and efficient to identify and quantify this type of adulterant in which 100% of the samples were correctly classified and the average relative error was approximately 4% in the range 0.5-25% (w/w).

[Review of the different methods for the evaluation of the in vitro antioxidant activity of wine and study of in vivo effects]. / Revisión de los métodos de evaluación de la actividad antioxidante in vitro del vino y valoración de sus efectos in vivo.

The aim of this paper is to evaluate the significance of these methods, as well as to correlate the antioxidant activity of wines with their phenolic profile, both in qualitative and quantitative terms. Red wines show higher antioxidant capacities than white ones and the magnitude of these differences depends on the method used. The antioxidant activity of wine can not be mainly ascribed to a particular phenolic compound, instead it is explained by the global interaction of all of them. To evaluate the influence of red wine consumption in the human organism, plasma antioxidant capacity has been frequently used as biomarker, and studies have shown that it increases after wine ingestion. We can conclude that it is necessary to use a battery of methods that provide different and complementary information to properly interpret the results. Phenolic compounds undergo metabolic transformations in the organism which modify their activities. In vivo assays do consider these changes. From the studies performed up to date we can conclude that acute ingestion of wine directly acts on plasma antioxidant capacity due to phenolic compounds and indirectly influences by means of changes on plasmatic concentration of endogenous antioxidants.

Counting of residual WBCs in WBC-reduced blood components: a multicenter evaluation of a microvolume fluorimeter by the United Kingdom National Blood Service.

BACKGROUND: Implementation of universal WBC reduction of blood components means that automated analytical methods may be the only satisfactory way for production laboratories to meet increased testing requirements. STUDY DESIGN AND METHODS: A multicenter study on the performance of a microvolume fluorimeter (IMAGN 2000, Becton Dickinson) was undertaken on 519 RBC, 353 platelet, and 27 fresh plasma units. RESULTS: WBC counts for the RBC samples ranged from 0.02 to 6.94 x 10(6) per unit (mean, 0.57) as determined by FC and from 0.02 to 5.53 x 10(6) per unit (mean, 0.40) as determined by MVF with a mean FC bias of +0.15 x 10(6) WBCs per unit, and discrepancies outside the 95% limits of agreement were mainly associated with higher FC counts. The series of platelet samples showed means of 0.90 (range, 0.06-19.45) and 0.66 (range, 0.01-18.95) x 10(6) WBCs per unit for FC and MVF methods, respectively. FC and MVF results were in good agreement at low counts, although significant discrepancies were noted at higher counts. Overall, for the platelet units, there was a mean FC bias of +0.34 x 10(6) WBCs per unit. The intermethod agreement exceeded 99 percent for both types of blood component when the single (both UK and United States) decision point of 5.0 x 10(6) WBCs per unit was applied. The mean WBC counts for the 27 analyzed fresh plasma units were 61.8, 56.0, and 46.0 per microL by Nageotte hemocytometry, FC, and MVF, respectively. CONCLUSIONS: This evaluation found that the level of intersite consistency for FC was relatively poor compared to that for MVF. The results nevertheless validated the broad equivalence of FC and MVF results for the current Council of Europe and UK/US decision points of <1.0 and <5.0 x 10(6) WBCs per unit.